Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:865-871

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salas, S. P.
Right arrow Articles by Vío, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salas, S. P.
Right arrow Articles by Vío, C. P.

(Hypertension. 1999;34:865-871.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Long-Term Nitric Oxide Synthase Inhibition in Rat Pregnancy Reduces Renal Kallikrein

Sofía P. Salas; José F. Vuletin; Andrea Giacaman; Pedro Rosso; Carlos P. Vío

From the Center for Medical Research (S.P.S., J.F.V., A.G., P.R.) and the Departments of Obstetrics and Gynecology (S.P.S.) and Pediatrics (P.R.), School of Medicine, and the Department of Physiology (C.P.V.), Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.

Abstract—This study was performed to test the hypothesis that long-term nitric oxide synthase (NOS) inhibition during pregnancy may alter the predominance of the vasodilator kallikrein system. Sprague-Dawley rats were treated with the competitive inhibitor of NOS N{omega}-nitro-L-arginine (L-NNA, 50 mg · kg-1 · d-1, dissolved in water) from days 7 to 21 of pregnancy. Rats were studied before treatment (day 5), at days 11, 17, and 21 of pregnancy (during treatment), and at postpartum days 7 and 21 (after the drug was withdrawn at delivery). Each group (n=5 to 8) had its corresponding control group (C) that received only vehicle. Additional rats were treated with NG-nitro-L-arginine methyl ester (L-NAME) alone or with an excess of L-arginine. At each study day, we measured blood pressure, collected urine overnight, obtained blood samples, and processed the kidneys for conventional histology and immunohistochemistry. In L-NNA rats, fetal and placental weights were reduced at days 17 and 21. Blood pressure was higher at days 17 and 21, returning to normal after L-NNA was removed. Urinary kallikrein activity was lower at days 11 and 17 (L-NNA=1147±213 and C=2317±146 nmol/16 h, P<0.001). Plasma renin activity was reduced at day 21 (L-NNA=9.6±2.1 and C=25.9±5 ng · mL-1 · h-1, P<0.05) and remained lower at postpartum day 7. L-NNA rats exhibited glomerular lesions and tubular atrophy, particularly of connecting tubules that displayed reduced kallikrein staining. Tubulointerstitial infiltrating macrophages (ED1+) were also observed. Renal lesions were present as early as day 11 and persisted at day 7 postpartum. L-NAME rats exhibited similar alterations that were attenuated with an excess of L-arginine. We postulate that the reduction in renal kallikrein may contribute to the hemodynamic alterations described in this model.


Key Words: pregnancy • nitric oxide • plasma renin activity • renal kallikrein • renal lesions • macrophages




This article has been cited by other articles:


Home page
HypertensionHome page
S. P. Salas, A. Giacaman, W. Romero, P. Downey, E. Aranda, D. Mezzano, and C. P. Vio
Pregnant Rats Treated With a Serotonin Precursor Have Reduced Fetal Weight and Lower Plasma Volume and Kallikrein Levels
Hypertension, October 1, 2007; 50(4): 773 - 779.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. P. Basile, K. Fredrich, M. Alausa, C. P. Vio, M. Liang, M. R. Rieder, A. S. Greene, and A. W. Cowley Jr.
Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure
Am J Physiol Renal Physiol, May 1, 2005; 288(5): F953 - F963.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. P. Salas, A. Giacaman, and C. P. Vio
Renal and Hormonal Effects of Water Deprivation in Late-Term Pregnant Rats
Hypertension, September 1, 2004; 44(3): 334 - 339.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. P. Salas, A. Giacaman, and C. P. Vio
Pregnant Rats With 5/6 Nephrectomy Have Normal Volume Expansion Despite Lower Renin and Kallikrein
Hypertension, October 1, 2003; 42(4): 744 - 748.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S.-I. Suga, M. I. Phillips, P. E. Ray, J. A. Raleigh, C. P. Vio, Y.-G. Kim, M. Mazzali, K. L. Gordon, J. Hughes, and R. J. Johnson
Hypokalemia induces renal injury and alterations in vasoactive mediators that favor salt sensitivity
Am J Physiol Renal Physiol, October 1, 2001; 281(4): F620 - F629.
[Abstract] [Full Text] [PDF]